Prognosis of patients with stage IIIb-IVa squamous cell carcinoma of the cervix following intra-arterial neoadjuvant chemotherapy

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 2, 1999, Pages 143-146

  Fujiwaki, R ^a   Maede, Y ^a   Ohnishi, Y ^a   Watanabe, Y ^a   Hata, K ^a   Miyazaki, K ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Cervical carcinoma; Intra arterial neoadjuvant chemotherapy; Prognosis; Squamous cell carcinoma; Stage IIIb and IVa

Indexed keywords

CISPLATIN; PEPLEOMYCIN; SQUAMOUS CELL CARCINOMA ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0032805272     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hoskins W.J., Peres C.A., Young R.C. Uterine cervix. In: Perez C.A., Kurman R.J., Stehman F.B., Thigpen J.T., eds. Principles and practice of gynecologic oncology. Philadelphia: J.B. Lippincott, 1992: 591-662.
2. Stehman F.B., Bundy B.N., DiSaia P.J., Keys H.M., Larson J.E., Fowler W.C. Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in Gynecologic Oncology Group. Cancer 67:2776-2785, 1991.
3. Meanwell C.A., Kelly K.A., Wilson S., et al. Young age as a prognostic factor in cervical cancer: analysis of population based data from 10022 cases. Br Med J 296:386-391, 1988.
4. Prempree T., Patanaphan V., Sewchand W., Scott R.M. The influence of patient's age and tumor grade on the prognosis of carcinoma of the cervix. Cancer 51:1764-1771, 1983.
5. Fujiwaki R., Iida K., Ohnishi Y., et al. Intra-arterial neoadjuvant chemotherapy followed by radical surgery and radiotherapy for stage IIb cervical carcinoma. Anticancer Res 17:3751-3756, 1997.
6. Kohno Y., Iwanari O., Kitao M. Prognostic importance of histologic vascular density in cervical cancer treated with hypertensive intraarterial chemotherapy. Cancer 72:2394-400, 1993.
7. Toita T., Sakumoto K., Higashi M., et al. Therapeutic value of neoadjuvant intra-arterial chemotherapy (cisplatin) and irradiation for locally advanced uterine cervical cancer. Gynecol Oncol 65:421-4, 1997.
8. Scarabelli C., Zarrelli A., Gallo A., Visentin M. Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIb-IVa cervical cancer. Cancer 76:1019-26, 1995.
9. Patton T.J., Kavanagh J.J., Delclos L., et al. Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina. Gynecol Oncol 42:54-9, 1991.
10. Kigawa J., Minagawa Y., Ishihara H., Itamochi H., Kanamori Y., Terakawa N. The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am J Clin Oncol 19:255-9, 1996.
11. Park S.Y., Kim B.G., Kim J.H., et al. Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinoma. Cancer 76:814-823, 1995.
12. Rettenmier M.A., Moran M.F., Ramsinghani N.F., et al. Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatin. Cancer 61:1301-1303, 1988.
13. Fujiwaki R., Takahashi K., Kitao M. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma. Gynecol Oncol 65:258-264, 1997.
14. Brader K.R., Morris M., Levenback C., Levy L., Lucas K.R., Gershenson D.M. Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 16:1879-84, 1998.